Jones, Katherine

Eligibility for the Donanemab Trial in a Population-Based Study of Cognitive Aging (N4.001)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000204786